Mi Jian
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 11
- Colorectal Cancer Surgical Treatments 4
- Colorectal Cancer Treatments and Studies 3
- Cancer Cells and Metastasis 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Co-authors
- Ye Wei (13 shared papers)Jianmin Xu (9 shared papers)Li Ren (10 shared papers)Meiling Ji (7 shared papers)Guodong He (7 shared papers)Liangliang Yang (3 shared papers)Zhengchuan Niu (3 shared papers)Qi Lin (7 shared papers)
- Journals
- Vox Sanguinis (2 papers)Cancer Management and Research (2 papers)Journal of Clinical Oncology (1 paper)Surgical Endoscopy (1 paper)APL Bioengineering (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Mi Jian
22 papers receiving 406 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 137
- Hepatology 37
- Oncology 111
- Molecular Biology 174
- Immunology 33
Countries citing papers authored by Mi Jian
This map shows the geographic impact of Mi Jian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Jian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Jian more than expected).
Fields of papers citing papers by Mi Jian
This network shows the impact of papers produced by Mi Jian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Jian. The network helps show where Mi Jian may publish in the future.
Co-authors
The 25 scholars most cited alongside Mi Jian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 137 | |
| 2 | 2020 | 61 | |
| 3 | 2019 | 58 | |
| 4 | 2020 | 31 | |
| 5 | 2015 | 31 | |
| 6 | 2019 | 19 | |
| 7 | 2019 | 18 | |
| 8 | 2018 | 11 | |
| 9 | 2018 | 11 | |
| 10 | Patients with RAS wild-type right-sided unresectable liver-confined mCRC also benefit from cetuximab plus chemotherapy in first-line treatment. | 2018 | 7 |
| 11 | 2020 | 5 | |
| 12 | Prognostic impact of KRAS and BRAF mutations in patients who underwent simultaneous resection for initially resectable colorectal liver metastases. | 2018 | 4 |
| 13 | 2022 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 2019 | 2 | |
| 16 | 2025 | 2 | |
| 17 | Clinical Observations on the Reducing Effect of Yin Meridian Electroacupuncture on Muscular Tension of Limb in Apoplectic Hemiplegia | 2003 | 1 |
| 18 | 2024 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2023 | 1 |
About Mi Jian
Mi Jian is a scholar working on Oncology, Hepatology, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 28 papers that have together received 408 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Colorectal Cancer Surgical Treatments (4 papers), Immune cells in cancer (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Gastric Cancer Management and Outcomes (3 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (137 citations), Hepatology (37 citations), Oncology (111 citations), Molecular Biology (174 citations) and Immunology (33 citations). Mi Jian has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Ye Wei, Jianmin Xu, Li Ren, Meiling Ji, Guodong He, Liangliang Yang, Zhengchuan Niu, Qi Lin, Wenju Chang and Tianyu Liu. Their work appears in journals such as Vox Sanguinis, Cancer Management and Research, Journal of Clinical Oncology, Surgical Endoscopy and APL Bioengineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.